Literature DB >> 19201339

Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients.

Kathleen Blondeau1, Veerle Mertens, Bart A Vanaudenaerde, Geert M Verleden, Dirk E Van Raemdonck, Daniel Sifrim, Lieven J Dupont.   

Abstract

BACKGROUND: Gastroesophageal reflux (GER) and aspiration of bile acids have been implicated as non-alloimmune risk factors for the development of bronchiolitis obliterans syndrome (BOS) after lung transplantation. The aim of our study was to investigate the association between GER and gastric aspiration of bile acids and to establish which reflux characteristics may promote aspiration of bile acids into the lungs and may feature as a potential diagnostic tool in identifying lung transplantation (LTx) patients at risk for aspiration.
METHODS: Twenty-four stable LTx recipients were studied 1 year after transplantation. All patients underwent 24-hour ambulatory impedance-pH recording for the detection of acid (pH <4) and weakly acidic (pH 4 to 7) reflux. On the same day, bronchoalveolar lavage fluid (BALF) was collected and then analyzed for the presence of bile acids (Bioquant enzymatic assay).
RESULTS: Increased GER was detected in 13 patients, of whom 9 had increased acid reflux and 4 had exclusively increased weakly acidic reflux. Sixteen patients had detectable bile acids in the BALF (0.6 [0.4 to 1.5] micromol/liter). The 24-hour esophageal volume exposure was significantly increased in patients with bile acids compared to patients without bile acids in the BALF. Acid exposure and the number of reflux events (total, acid and weakly acidic) were unrelated to the presence of bile acids in the BALF. However, both nocturnal volume exposure and the number of nocturnal weakly acidic reflux events were significantly higher in patients with bile acids in the BALF.
CONCLUSIONS: Weakly acidic reflux events, especially during the night, are associated with the aspiration of bile acids in LTx recipients and may therefore feature as a potential risk factor for the development of BOS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201339     DOI: 10.1016/j.healun.2008.11.906

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  15 in total

1.  Advances in GERD: Current Developments in the Management of Acid-Related GI Disorders.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-01

2.  Gastroesophageal reflux disease after lung transplantation: pathophysiology and implications for treatment.

Authors:  Christopher S Davis; Vidya Shankaran; Elizabeth J Kovacs; James Gagermeier; Daniel Dilling; Charles G Alex; Robert B Love; James Sinacore; P Marco Fisichella
Journal:  Surgery       Date:  2010-08-21       Impact factor: 3.982

Review 3.  Gastroesophageal reflux and altered motility in lung transplant rejection.

Authors:  J M Castor; R K Wood; A J Muir; S M Palmer; R A Shimpi
Journal:  Neurogastroenterol Motil       Date:  2010-05-26       Impact factor: 3.598

4.  Posaconazole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapy.

Authors:  Ryan K Shields; Cornelius J Clancy; Aniket Vadnerkar; Eun J Kwak; Fernanda P Silveira; Rima C Abdel Massih; Joseph M Pilewski; Maria Crespo; Yoshiya Toyoda; Jay K Bhama; Christian Bermudez; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

5.  The prevalence and extent of gastroesophageal reflux disease correlates to the type of lung transplantation.

Authors:  Piero Marco Fisichella; Christopher S Davis; Vidya Shankaran; James Gagermeier; Daniel Dilling; Charles G Alex; Elizabeth J Kovacs; Raymond J Joehl; Robert B Love
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2012-02       Impact factor: 1.719

6.  Laparoscopic antireflux surgery for gastroesophageal reflux disease after lung transplantation.

Authors:  P Marco Fisichella; Christopher S Davis; James Gagermeier; Daniel Dilling; Charles G Alex; Jennifer A Dorfmeister; Elizabeth J Kovacs; Robert B Love; Richard L Gamelli
Journal:  J Surg Res       Date:  2011-06-22       Impact factor: 2.192

7.  The Intersection of GERD, Aspiration, and Lung Transplantation.

Authors:  Marco G Patti; Marcelo F Vela; David D Odell; Joel E Richter; P Marco Fisichella; Michael F Vaezi
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2016-05-24       Impact factor: 1.878

Review 8.  Esophageal Dysmotility, Gastro-esophageal Reflux Disease, and Lung Transplantation: What Is the Evidence?

Authors:  Richard K Wood
Journal:  Curr Gastroenterol Rep       Date:  2015-12

9.  Extra-esophageal manifestations of gastroesophageal reflux disease: controversies between epidemiology and clicnic.

Authors:  Hamid Saber; Mostafa Ghanei
Journal:  Open Respir Med J       Date:  2012-11-02

10.  Biomarkers for gastroesophageal reflux in respiratory diseases.

Authors:  Ossur Ingi Emilsson; Thornórarinn Gíslason; Anna-Carin Olin; Christer Janson; Isleifur Olafsson
Journal:  Gastroenterol Res Pract       Date:  2013-04-09       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.